Best Practices for the Integration of Continuous Glucose Monitoring Within the Health System

Stream Link: https://event.arraylive.com/app/login/5f6ac57b-718c-4d3a-b57c-6c285ab3307b

This activity is part 2 of a 3-part curriculum and includes interactive patient counseling video vignettes.

Program Description

Patients with diabetes who are hospitalized and have uncontrolled blood glucose levels are at a higher risk for morbidity, mortality, and health care costs. Pharmacists practicing within hospital and health-system settings can identify patients who might benefit from continuous glucose monitoring (CGM) devices. This program will outline responsibilities for health-system pharmacists to improve the integration of CGM into practice for appropriate patients. The panelists will discuss insurance coverage options, potential cost considerations, and the importance of follow-up communication with patients to address initial challenges. Panelists will share their collective experience and discuss opportunities for collaboration to ensure a smooth transition to CGM use after discharge.

Target audience: Health-system and community pharmacists

Type of activity: Application
Release date: August 13, 2024
Expiration date: October 13, 2024

Time to complete activity: 1.5 hours

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Distinguish the role of continuous glucose monitoring (CGM) in improving outcomes for people with diabetes in the inpatient setting
• Analyze supportive evidence for the use of available CGM devices in the management of diabetes in the hospital setting
• Identify best practices to reduce barriers to the use of CGM for hospitalized people with diabetes
• Employ effective patient education and provider tools across the health system to expand access and enhance efficacy of CGM devices in the management of people with diabetes

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-24-177-L01-P. The activity is available for CE credit through October 13, 2024.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

Matt Baker, PharmD, MS, BCPS, has the following financial relationships with commercial interests to disclose:
Grant/Research Support: Dexcom

Consultant: Dexcom

Amy C. Donihi, PharmD, BCPS, BC-ADM, FCCP, has the following financial relationships with commercial interests to disclose:

Other Support (certified pump trainer): Tandem Diabetes Care, Inc, Medtronic, Beta Bionics, Omnipod (Insulet Corp)

Eileen R. Faulds, PhD, FNP-BC, RN, CDCES, has the following financial relationships with commercial interests to disclose:

Grant/Research Support: Dexcom LLC, Insulet LLC

Consultant: Dexcom LLC

Speaker's Bureau: Dexcom LLC

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.[CT1]

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms